Abstract
In the presence of Ro 20-1724, a selective inhibitor of cyclic nucleotide phosphodiesterase, carbamylcholine increases cAMP and cGMP levels in human thyroid cells in primary culture. The increase of cAMP exhibited at concentrations of carbamylcholine between 10 fM and 10 pM, is dose- and time-dependent, it is maximum after 30 min and is abolished after 60 min. At higher carbamylcholine concentration (10 μM), cAMP increases rapidly, becoming maximum after 15 min, but returns to unstimulated values after 30 min. The increase of cGMP is also dose- dependent (0.1 nM–10 μM); it reaqqches the maximum after 30 min and returns to unstimulated values after 120 min. A significant increase of phosphodiesterase activity is observed at 10 μM carbamylcholine. Atropine, a muscarinic receptor antagonist, blocks carbamylcholine effects on both cAMP and cGMP production without affecting the thyrotropin-induced cAMP accumulation. Hexamethonium, a nicotinic receptor antagonist does not affect the cholinergic effects. In the presence of Ro 20-1724, 10 μM carbamylcholine significantly inhibits the effect of thyrotropin on cAMP production, while the combined addition of low doses of carbamylcholine and thyrotropin (0.1 nM and 10 pM, respectively) results in ah additive effect on cAMP levels. Inhibition of thyrotropin activity on cAMP production, similar to that exerted by 10 μM carbamylcholine is produced by increasing free intracellular calcium; this inhibition is relieved by using a calmodulin-sensitive phosphodiesterase inhibitor, M and B 22948 at 50 μM dose. High concentrations (10 μM) of carbamylcholine increase the adenylate cyclase activity, without any significant effect on the thyrotropin-induced activation of the enzyme. The data presented in this study show, for the first time, that in primary cultures of human thyroid cells, cAMP production is increased by a cholinergic agent acting through muscarinic receptors. Cholinergic activity can either potentiate or inhibit thyrotropin action depending on the concentration of neurotransmitter available. Accelerated catabolism by the activation of the calmonodulin-sensitive phosphodiesterase can explain the inhibitory effect of carbamylcholine on the cellular accumulation of cAMP.
Similar content being viewed by others
References
Melander A., Sundler F., Westgren U. Intrathyroidal amines and the synthesis of thyroid hormones. Endocrinology 93: 193, 1973.
Melander A., Sundler F. Presence and influence of cholinergic nerves in the mouse thyroid. Endocrinology 105: 7, 1979.
Van Sande J., Dumont J.E., Melander A., Sundler F. Presence and influence of cholinergic nerves in the human thyroid. J. Clin. Endocrinol. Metab. 51: 500, 1980.
Pastan I., Katzen H. Activation of adenyl cyclase in thyroid homogenates by thyroid stimulating hormone Biochem. Biophys. Res. Commun. 29: 792, 1967.
Kaneko T., Zor U., Field J.B. Thyroid stimulating hormone and prostaglandin E1 stimulation of cyclic 3′,5′-adenosine monophosphate in thyroid slices. Science 163: 1052, 1969.
Yamashita K., Field J.B. Elevation of cyclic 3′,5′ monophosphate levels in dog thyroid slices caused by acetylcholine and sodium chloride. J. Biol. Chem. 247: 7062, 1972.
Van Sande J., Erneux C., Dumont J.E. Control and role of cyclic 3′,5′-guanosine monophosphate in the thyroid. Biochem. Biophys. Res. Commun. 62: 168, 1975.
Van Sande J., Erneux C., Dumont J.E. Negative control action by iodine and acetylcholine mechanism of action in thyroid cells. J. Cyclic Nucleotide Res. 3: 335, 1977.
Van Sande J., Decostor C., Dumont J.E. Effects of carbamylcholine and ionophore A-23187 on cyclic 3′5′-AMP and cyclic 3′5′-GMP accumulation in dog thyroid slices. Mol. Cell. Endocrinol. 14: 45, 1979.
Champion S., Mauchamp J. Muscarinic cholinergic receptors on cultured thyroid cells. I. Biological effects of carbachol and characterization of the receptors. Mol. Pharmacol. 21: 66, 1982.
Brandi M.L., Rotella C.M., Tanini A., Toccafondi R. Evidence for alpha-adrenergic receptors acting through the guanylate cyclase system in human thyroid cultured cells. Acta Endocrinol. (Kbh.) 104: 64, 1983.
Brandi M.L., Rotella C.M., Lopponi A., Kohn L.D., Aloj S.M., Toccafondi R. Forskolin perturbs cGMP as well as cAMP levels in human thyroid cells. Acta Endocrinol. (Kbh.) 107: 237, 1984.
Winand R.J., Kohn L.D. Relationships of thyrotropin to exophtalmic-producing substance: purification of homogeneous glycoproteins containing both activities from [3H]-labeled pituitary extracts. J. Biol. Chem. 245: 967, 1970.
Kohn L.D., Winand R.J. Structure of an exophthalmos-producing factor derived from thyrotropin by partial pepsin digestion. J. Biol. Chem. 250: 6503, 1975.
McKenzie J.M. The bioassay of thyrotropin in serum. Endocrinology 63: 372, 1958.
Vitti P., Rotella C.M., Valente W.A., Cohen J., Aloj S.M., Laccetti P., Ambesi-Impiombato F.S., Grollman E.F., Pinchera A., Toccafondi R., Kohn L.D. Characterization of the optimal stimulatory effects of Graves’ monoclonal and serum immunoglobulin G on adenosine 3′,5′-monophosphate production in FRTL-5 thyroid cells: a potential clinical assay. J. Clin. Endocrinol. Metab. 57; 782, 1983.
Toccafondi R., Aterini S., Medici M.A., Rotella C.M., Tanini A., Zonefrati R. Thyroid stimulating antibody (TSAb) detected in sera of Graves’ patients using human thyroid cell cultures. Clin. Exp. Immunol. 40: 532, 1980.
Jacquemont C., Prunieras M. Culture de longue durée de cellules issue de l’epiderme de cobaye adulte. Pathol. Biol. 17: 243, 1969.
Brown B.L., Ekins R.P., Albano J.D.M. Saturation assay for cAMP using endogenous binding protein. In: Greengard, Robinson (Eds.), Advances in cyclic nucleotide research. Raven Press, New York, 1972, Vol. 2, p. 25.
Steiner A.L., Wehmann R.E., Parker C.W., Kipnis D.M. Radioimmunoassay for the measurement of cyclic nucleotides. In: Greengard, Robinson (Eds.), Advances in cyclic nucleotide research. Raven Press, New York, 1972, Vol. 2, p. 51.
Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J. 62: 315, 1956.
Arcangeli P., Toccafondi R., Rotella C.M., Aterini S., Borrelli D., Loddi L. Dissociation in the response of the adenylate cyclase system to thyrotropin and prostaglandin E2 in human thyroid carcinoma tissue. Cancer 48: 757, 1981.
Lowry C.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265, 1951.
Toccafondi R., Rotella C.M., Tanini A., Fani P., Arcangeli P. Thyrotropin-responsive adenylate cyclase activity in thyroid toxic adenoma. Acta Endocrinol. (Kbh.) 92: 658, 1979.
Amir S.M., Carraway Jr. T.F., Kohn L.D., Winand R.J. The binding of thyrotropin to isolate bovine thyroid plasma membranes. J. Biol. Chem. 248: 4092, 1973.
Albano J.D.M., Maudsley D.V., Brown B.L., Barnes G.D. A simplified procedure for the determination of adenylate cyclase activity. Biochem. Soc. Trans. 1: 477, 1973.
Miot F., Erneux C., Wells J.N., Dumont J.E. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine. Mol. Pharmacol. 25: 261, 1984.
Patrono C., Rotella C.M., Toccafondi R., Aterini S., Pinca E., Tanini A., Zonefrati R. Prostacyclin stimulates the adenylate cyclase system of human thyroid tissue. Prostaglandins 22: 105, 1981.
Toccafondi R., Brandi M.L., Melander A. Vasoactive intestinal peptide stimulation of human thyroid cell function. J. Clin. Endocrinol. Metab. 58: 157, 1984.
Jakobs K.H., Aktories K., Schultz G. GTP-dpendent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agents. Naunyn — Schmiedebergs Arch. Pharmacol. 310: 113, 1979.
Oron Y., Kelog J., Larner J. Stable cholinergic muscarinic inhibition of rat parotid adenylate cyclase. FEBS Lett. 94: 331, 1978.
Meeker R.B., Harden T.K. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism: agonist-induced changes in nucleotide synthesis and degradation. Mol. Pharmacol. 23: 384, 1983.
Erneux C., VanSande J., Dumont J.M., Boeynaems J.M. Cyclic nucleotide hydrolysis in the thyroid gland. General properties and their role in the interrelations of adenosine 3′,5′-monophosphate. Eur. J. Biochem. 72: 137, 1977.
Miot F., Dumont J.E., Erneux C. The involvement of a calmodulin-dependent phosphodiesterase in the negative control of carbamylcholine on cyclic AMP levels in dog thyroid slices. FEBS Lett. 151: 273, 1983.
Marchmont R.J., Houslay M.D. Insulin triggers cyclic AMP-dependent activation and phosphorylation of a plasma membrane cyclic AMP phosphodiesterase. Nature 286: 904, 1980.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brandi, M.L., Rotella, C.M., Tanini, A. et al. Cholinergic control of cyclic nucleotide metabolism in human thyroid cells. J Endocrinol Invest 10, 451–458 (1987). https://doi.org/10.1007/BF03348169
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348169